Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
Tien DamAdam L BoxerLawrence I GolbeGünter U HöglingerHuw R MorrisIrene LitvanAnthony E LangJean-Christophe CorvolIkuko AibaMichael GrundmanLili YangBeth Tidemann-MillerJoseph KupfermanKristine HarperKubra KamisogluMichael J WaldDanielle L GrahamLiz GedneyJohn O'GormanSamantha Budd Haeberleinnull nullPublished in: Nature medicine (2022)